Regeneron Pharmaceuticals | REGN - Ebitda





Ebitda Perubahan Tanggal
AbbVie USD 6.91B 3.22B 2026-06
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Astellas Pharma JPY 182.02B 53.22B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
J&J USD 8.99B 721M 2026-06
Kyowa Hakko Kirin JPY 34.07B 19.84B 2026-09
Merck USD 1.42B 2.97B 2026-06
Moderna USD -687M 571M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.36B 45M 2026-09
Pfizer USD 6.36B 350M 2026-09
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 6.66B 4.99B 2026-09
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Teva Pharmaceutical Industries USD 1.5B 1.02B 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
United Therapeutics USD 334.2M 20.8M 2026-09
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09